[1] GHOSH S.Cisplatin:The first metal based anticancer drug[J].Bioorg Chem,2019,88:102925.
[2] EL SI,ABDEL-LATIF GA,FARAG DB,et al.Ameliorative effect of betanin on experimental cisplatin-induced liver injury;the novel impact of miRNA-34a on the SIRT1/PGC-1α signaling pathway[J].J Biochem Mol Toxicol,2021,35(6):1-14.
[3] TAN X,ZHOU Y,AGARWAL A,et al.Systemic application of honokiol prevents cisplatin ototoxicity without compromising its antitumor effect[J].Am J Cancer Res,2020,10(12):4416-4434.
[4] ZHENG Z,MA Y,WANG L,et al.Chinese herbal medicine Feiyanning cooperates with cisplatin to enhance cytotoxicity to non-small-cell lung cancer by inhibiting protective autophagy[J].J Ethnopharmacol,2021,276:114196.
[5] LU X,DENG T,DONG H,et al.Novel application of eupatilin for effectively attenuating cisplatin-induced auditory hair cell death via mitochondrial apoptosis pathway[J/OL].Oxid Med Cell Longev,2022,2022:1090034[2022-03-30].https://doi.org/10.1155/2022/1090034.
[6] HU B,LIU Y,CHEN X,et al.Ferrostatin-1 protects auditory hair cells from cisplatin-induced ototoxicity in vitro and in vivo[J].Biochem Biophys Res Commun,2020,533(4):1442-1448.
[7] DASARI VR,CAREY DJ,GOGOI R.Synergistic enhancement of efficacy of platinum drugs with verteporfin in ovarian cancer cells[J].BMC Cancer,2020,20(1):273.
[8] DINAN L,DIOH W,VEILLET S,et al.20-hydroxyecdysone,from plant extracts to clinical use:therapeutic potential for the treatment of neuromuscular,cardio-metabolic and respiratory diseases[J].Biomedicines,2021,9(5):492.
[9] MALLEK A,MOVASSAT J,AMEDDAH S,et al.Experimental diabetes induced by streptozotocin in the desert gerbil,gerbillus gerbillus,and the effects of short-term 20-hydroxyecdysone administration[J].Biomed Pharmacother,2018,102:354-361.
[10] SBUNIAM J,CHUKIJRUNGROAT N,RATTANAVICHIT Y,et al.20-hydroxyecdysone ameliorates metabolic and cardiovascular dysfunction in high-fat-high-fructose-fed ovariectomized rats[J].BMC Complement Med Ther,2020,20(1):140.
[11] RIESWIJK L,LIZARRAGA D,BRAUERS KJ,et al.Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes,HepG2 cells and mouse embryonic stem cells shows conservation of regulating transcription factor networks[J].Mutagenesis,2014,29(1):17-26.
[12] SANTOS N,FERREIRA RS,SANTOS ACD.Overview of cisplatin-induced neurotoxicity and ototoxicity,and the protective agents[J].Food Chem Toxicol,2020,136:111079.
[13] WANG Y,HU PC,GAO FF,et al.The protective effect of curcumin on hepatotoxicity and ultrastructural damage induced by cisplatin[J].Ultrastruct Pathol,2014,38(5):358-362.
[14] HAMZEH M,HOSSEINIMEHR SJ,KHALATBARY AR,et al.Atorvastatin mitigates cyclophosphamide-induced hepatotoxicity via suppression of oxidative stress and apoptosis in rat model[J].Res Pharm Sci,2018,13(5):440-449.
[15] CHEN Y,ZHAO C,LIU X,et al.Plumbagin ameliorates liver fibrosis via a ROS-mediated NF-κB signaling pathway in vitro and in vivo[J].Biomed Pharmacother,2019,116:108923.
[16] ZHAO K,WEN LB.DMF attenuates cisplatin-induced kidney injury via activating Nrf2 signaling pathway and inhibiting NF-κB signaling pathway[J].Eur Rev Med Pharmacol Sci,2018,22(24):8924-8931.
[17] YOON JH,YOUN K,JUN M.Protective effect of sargahydroquinoic acid against Aβ(25-35)-evoked damage via PI3K/Akt mediated Nrf2 antioxidant defense system[J].Biomed Pharmacother,2021,144:112271.
[18] VASHI R,PATEL BM.NRF2 in cardiovascular diseases:a ray of hope[J].J Cardiovasc Transl Res,2021,14(3):573-586.
[19] MISHRA V,BANGA J,SILVEYRA P.Oxidative stress and cellular pathways of asthma and inflammation:Therapeutic strategies and pharmacological targets[J].Pharmacol Ther,2018,181:169-182.
[20] IVANOV AV,VALUEV-ELLISTON VT,TYURINA DA,et al.Oxidative stress,a trigger of hepatitis C and B virus-induced liver carcinogenesis[J].Oncotarget,2017,8(3):3895-3932.
[21] BENDER D,HILDT E.Effect of hepatitis viruses on the Nrf2/Keap1-signaling pathway and its impact on viral replication and pathogenesis[J].Int J Mol Sci,2019,20(18):4659.
[22] IBRAHIM FG,AHMED KA.Curcumin ameliorates doxorubicin-induced cardiotoxicity and hepatotoxicity via suppressing oxidative stress and modulating iNOS,NF-κB,and TNF-α in rats[J].Cardiovasc Toxicol,2022,22(2):152-166.
[23] MILIARAKI M,BRIASSOULIS P,ILIA S,et al.Oxidant/antioxidant status is impaired in sepsis and is related to anti-apoptotic,inflammatory,and innate immunity alterations[J/OL].Antioxidants (Basel),2022,11(2):231[2022-03-30].https://doi.org/10.3390/antiox11020231.
[24] CIESLAR-POBUDA A,AHRENS TD,CAGLAYAN S,et al.DNMT3B deficiency alters mitochondrial biogenesis and α-ketoglutarate levels in human embryonic stem cells[J].Stem Cells,2020,38(11):1409-1422.
[25] PATIL V,CUENIN C,CHUNG F,et al.Human mitochondrial DNA is extensively methylated in a non-CpG context[J].Nucleic Acids Res,2019,47(19):10072-10085.
[26] IGUCHI E,TAKAI A,TAKEDA H,et al.DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis[J].Sci Rep,2020,10(1):21268.
[27] PAUDEL R,FUSI L,SCHMIDT M.The MEK5/ERK5 pathway in health and disease[J].Int J Mol Sci,2021,22(14):7594.
[28] DI BL,GAGLIARDI PA,PULIAFITO A,et al.Serine/threonine kinase 3-phosphoinositide-dependent protein kinase-1 (PDK1) as a key regulator of cell migration and cancer dissemination[J].Cancers(Basel),2017,9(3):25.